Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer

Conditions: Breast Cancer Interventions: Drug: Adebrelimab; Drug: dalpiciclib Sponsors: Tongji Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials